Trigilio Jeffrey

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$94,500.00
Insider Sells Quantity
12
Insider Sells Sum
$689,703.15

Insider Activity of Trigilio Jeffrey

According to the SEC Form 4 filings, Trigilio Jeffrey, being in a position of

  1. Chief Financial Officer at Cullinan Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4244 shares for $34,634,
    over all time since 2021-01-12, has bought 4500 shares for $94,500, and sold 29823 shares for $689,703.

The largest purchase of all time was on 2021-01-12 and amounted to 4500 shares of Cullinan Oncology, Inc. for $94,500.

The largest sale of all time was on 2021-09-08 and amounted to 15000 shares of Cullinan Oncology, Inc. for $427,153.

Biography of Trigilio Jeffrey

No biography is available at this moment.

2023-12-21SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
1,920
0.004%
$8.50$16,320+82.97%
2023-12-18SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
398
0.0008%
$8.22$3,272+91.09%
2023-12-12SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
1,926
0.0045%
$7.81$15,042+119.97%
2023-06-20SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
399
0.001%
$12.94$5,163-16.68%
2023-06-12SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
319
0.0008%
$13.11$4,182-14.32%
2023-05-18SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
399
0.001%
$8.76$3,495+20.91%
2023-05-12SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
347
0.0008%
$8.78$3,047+8.4%
2023-04-18SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
398
0.001%
$10.71$4,263+1.46%
2023-04-12SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
318
0.0008%
$10.22$3,250+4.33%
2023-03-20SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
399
0.001%
$11.32$4,517-5.51%
2021-10-15SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
8,000
0.0186%
$25.00$200,000-46.64%
2021-09-08SaleCullinan Oncology, Inc.
CGEM
Chief Financial Officer
15,000
0.034%
$28.48$427,153-52.56%
2021-01-12PurchaseCullinan Oncology, Inc.
CGEM
Chief Financial Officer
4,500
0.0076%
$21.00$94,500-6.22%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.